Comment on Will Eli Lilly (LLY) Stock be Hurt Today by German Court's Patent Ruling?

Will Eli Lilly (LLY) Stock be Hurt Today by German Court's Patent Ruling?

NEW YORK (TheStreet) -- Eli Lilly shares are down 1.87% to $69.27 in early market trading on Friday after a German court ruled against it in a patent case involving its Alimta lung cancer drug.The court ruled that generic drug maker Actavis would not infringe on the company's patent by marketing an alternative salt form of the Alimta, known as pemetrexed, once the drug's compound patent expires at the end of this year."We strongly disagree with the ruling by the German Court of Appeal regarding Alimta's vitamin regimen patent," said the company's senior VP and general counsel Michael J.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News